Ingredion Inc. Announces Tate & Lyle Acquisition Approval

What Happened

• Ingredion Inc. disclosed under Regulation FD that on July 28, 2026 shareholders of Tate & Lyle PLC (incorporated in England and Wales) voted to approve Ingredion’s recommended all-cash acquisition of the entire issued and to be issued share capital of Tate & Lyle. The Acquisition was originally announced June 8, 2026 and described in Ingredion’s Form 8-K filed June 9, 2026. The Acquisition is intended to be implemented by a court‑sanctioned scheme of arrangement under Part 26 of the UK Companies Act 2026.

Key Details

• Shareholder approvals occurred at a Court Meeting and a subsequent general meeting convened by order of the High Court of Justice in England and Wales on July 28, 2026.
• The Acquisition is expected to complete in the second half of 2027, subject to satisfaction or waiver of remaining conditions.
• Remaining conditions include material antitrust approvals and sanction of the scheme by the Court.
• The filing is a Regulation FD disclosure on Form 8-K dated July 28, 2026 (referencing the June 9, 2026 8-K describing the deal).

Why It Matters

• The shareholder votes clear a key condition to closing, moving the transaction forward toward court approval and regulatory clearances. For investors, the timeline and outcome now hinge on antitrust approvals and the Court’s sanction — these are the principal remaining risks that will determine whether the deal completes in H2 2027.